Answers are grounded in this paper and cite their sources.
Background and objectives: Soft tissue cytopathology plays a vital role in the diagnosis and management of soft tissue neoplasms, necessitating a standardized classification system to improve diagnostic accuracy and guide clinical decision-making.This article provides a concise review of the World Health Organization (WHO) Reporting System for Soft Tissue Cytopathology and presents a practical diagnostic approach to soft tissue cytopathology.Methods:The WHO Reporting System is reviewed in conjunction with relevant literature.The reporting system employs a sixcategory framework: non-diagnostic, benign, atypical, soft tissue neoplasm of uncertain malignant potential, suspicious for malignancy, and malignant.Each category is associated with a corresponding risk of malignancy and recommended clinical management guidelines.This classification aligns with the WHO Classification of Soft Tissue and Bone Tumours (5 th edition) and incorporates cytomorphologic features, ancillary studies, and clinical correlation to enhance diagnostic reproducibility and communication among pathologists and clinicians.Results: The system supports a probabilistic approach to risk stratification, enabling more consistent diagnostic and therapeutic strategies.Conclusions: As molecular diagnostics and immunocytochemistry continue to advance, this framework provides a robust foundation for the interpretation of soft tissue fine-needle aspiration biopsies and optimized patient care.
No takes yet. Share an insight, caveat, or question.
Marilyn M. Bui (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: